TransSerum? FQ Fetal Bovine Serum
胎牛血清 FQ
| 目錄號(hào) | 規(guī)格 | 單價(jià) |
|---|---|---|
| FS301-02 | 500 ml | 4800 |
產(chǎn)品詳情介紹
本產(chǎn)品以健康胎牛血液為原料加工而成，經(jīng)3次0.1 μm微孔濾膜過(guò)濾，無(wú)支原體污染，不含BVDV、BPV等牛源病毒，內(nèi)毒素水平極低。培養(yǎng)細(xì)胞種類多，細(xì)胞生長(zhǎng)速度快，狀態(tài)好，適用于間充質(zhì)干細(xì)胞的培養(yǎng)。培養(yǎng)的細(xì)胞適用于多種下游實(shí)驗(yàn)。
TransSerum? FQ Fetal Bovine Serum成功培養(yǎng)的細(xì)胞
病毒檢測(cè)
通過(guò)免疫熒光抗體法檢測(cè)TransGen FQ血清中的病毒殘留，結(jié)果如下：
支原體檢測(cè)
使用全式金支原體檢測(cè)試劑盒 TransDetect? PCR Mycoplasma Detection Kit (FM311)對(duì)Company B和TransGen FQ血清進(jìn)行檢測(cè)，結(jié)果表明,Company B 和TransGen FQ血清均無(wú)支原體污染。
間充質(zhì)干細(xì)胞培養(yǎng)圖
配制含TransGen FQ 血清的生長(zhǎng)培養(yǎng)基，培養(yǎng)間充質(zhì)干細(xì)胞，在顯微鏡下觀察每一代細(xì)胞的形態(tài)。
普通細(xì)胞培養(yǎng)圖 (部分結(jié)果)
配制含有Company B 和TransGen FQ 血清的生長(zhǎng)培養(yǎng)基，培養(yǎng)不同類型的細(xì)胞，在顯微鏡下觀察每一代細(xì)胞的形態(tài)。
血清介紹視頻
1 Wang Y, Lv L, Liang H, et al. Clot structure-based physical-matching design of platelet cloaking nano-delivery system facilitates specific arteriovenous thrombolysis[J]. Chemical Engineering Journal, 2022.(IF 13.00)
2 Wang Z, Chen Z, Zhang Z, et al. Multifunctional high boron content MOFs nano-co-crystals for precise boron neutron capture therapy for brain glioma in situ[J]. Nano Today, 2022.(IF 18.96)
3 Xiang H, Yang J, Cao X, et al. Flexible and highly sensitive triboelectric nanogenerator with magnetic nanocomposites for cultural heritage conservation and human motion monitoring[J]. Nano Energy, 2022.(IF 19.06)
4 Liu H, Fan H, He P, et al. Prohibitin 1 regulates mtDNA release and downstream inflammatory responses[J]. The EMBO Journal, 2022.(IF 14.01)
5 Shen Y, Wang J, Li Y, et al. Structures of ACE2–SIT1 recognized by Omicron variants of SARS-CoV-2[J]. Cell Discovery, 2022.(IF 38.07)
6 Chen K, Zhou R, Liang H, et al. Reversing the pathological microenvironment by radiocatalytic sensitizer for local orthotopic osteosarcoma radiotherapy enhancement[J]. Nano Today, 2023.(IF 18.96)
7 Hou P, Wang X, Wang H, et al. The ORF7a protein of SARS-CoV-2 initiates autophagy and limits autophagosome-lysosome fusion via degradation of SNAP29 to promote virus replication[J]. Autophagy, 2022.(IF 13.39)
8 Liang H, Chen K, Xie J, et al. A Bone‐Penetrating Precise Controllable Drug Release System Enables Localized Treatment of Osteoporotic Fracture Prevention via Modulating Osteoblast‐Osteoclast Communication[J]. Small, 2023.(IF 15.15)
9 Wang Y, Lv L, Liang H, et al. Clot structure-based physical-matching design of platelet cloaking nano-delivery system facilitates specific arteriovenous thrombolysis[J]. Chemical Engineering Journal, 2022.(IF 13.00)
